First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Published Online: 2023-08-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Achim Rittmeyer•Aleksandra Szczesna•Alice M Biggane•Anh Tuan Le•Baohui Han•Christian Schulz•Dariusz Kowalski•David Vicente•Diego Cortinovis•Dingzhi Huang•Elen Höglander•Federico Cappuzzo•Geoffrey Liu•Hans Kristian Vollan•Jessica Reyes Contreras•Kumar Prabhash•Martin Reck•Mary Connors•Milena Perez Mak•Raffaele Califano•Ramon Palmero•Siow Ming Lee•Solange Peters•Stefanie Morris•Toby Talbot•Youyou Hu
